Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-22 06:26 am Sale | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | dievini Hopp BioTech holding GmbH & Co KG | 85,922,741 46% | -158,700 (-0.18%) | View |
| 2022-01-13 4:19 pm Unchanged | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | KfW | 115,601,965 61.8% | 0 (Unchanged) | View |
| 2022-01-13 4:14 pm Purchase | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | dievini Hopp BioTech holding GmbH & Co KG | 86,081,441 46% | 11,667 (+0.01%) | View |
| 2021-10-18 5:28 pm Sale | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | KfW | 115,601,965 61.9% | -1,788,443 (-1.52%) | View |
| 2021-10-15 1:21 pm Sale | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | dievini Hopp BioTech holding GmbH & Co KG | 86,069,774 46.1% | -1,449,193 (-1.66%) | View |
| 2021-02-01 3:33 pm Purchase | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | KfW | 117,390,408 63.1% | 368,750 (+0.32%) | View |
| 2020-08-24 5:03 pm Purchase | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | KfW | 117,021,658 65.8% | 117,021,658 (New Position) | View |
| 2020-08-24 4:12 pm Purchase | 13G | CUREVAC N V CUREVAC N V IN CON CVAC | GSK plc GSK | 14,935,721 8.4% | 14,935,721 (New Position) | View |
| 2020-08-24 10:44 am Purchase | 13D | CUREVAC N V CUREVAC N V IN CON CVAC | dievini Hopp BioTech holding GmbH & Co KG | 87,518,967 49.2% | 87,518,967 (New Position) | View |